The Estimates of the Health and Economic Burden of Dengue in Vietnam

[1]  M. F. Boni,et al.  Projected costs associated with school-based screening to inform deployment of Dengvaxia: Vietnam as a case study , 2018, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[2]  D. Shepard,et al.  Cost-effectiveness of dengue vaccination in ten endemic countries. , 2018, Vaccine.

[3]  Richard Barnett.  Dengue , 2017, The Lancet.

[4]  A. Farlow,et al.  A multi-country study of the economic burden of dengue fever: Vietnam, Thailand, and Colombia , 2017, PLoS neglected tropical diseases.

[5]  Alan D. Lopez,et al.  Measuring global health: motivation and evolution of the Global Burden of Disease Study , 2017, The Lancet.

[6]  T. Vos,et al.  Global, regional, and national incidence and prevalence, and years lived with disability for 328 diseases and injuries in 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016 , 2017 .

[7]  J. Rosselló,et al.  Infectious disease risk and international tourism demand , 2017, Health policy and planning.

[8]  T. Vo,et al.  Direct Medical Costs of Dengue Fever in Vietnam: A Retrospective Study in a Tertiary Hospital. , 2017, The Malaysian journal of medical sciences : MJMS.

[9]  Eva Harris,et al.  Dengue: knowledge gaps, unmet needs, and research priorities. , 2017, The Lancet. Infectious diseases.

[10]  Mary E. Wilson,et al.  Disease and economic burdens of dengue. , 2017, The Lancet. Infectious diseases.

[11]  E. Undurraga,et al.  Disease Burden of Dengue in the Philippines: Adjusting for Underreporting by Comparing Active and Passive Dengue Surveillance in Punta Princesa, Cebu City , 2017, The American journal of tropical medicine and hygiene.

[12]  L. Pham,et al.  Economic report on the cost of dengue fever in Vietnam: case of a provincial hospital , 2016, ClinicoEconomics and outcomes research : CEOR.

[13]  J. Stanaway,et al.  The global economic burden of dengue: a systematic analysis. , 2016, The Lancet. Infectious diseases.

[14]  Simon I Hay,et al.  The global burden of dengue: an analysis from the Global Burden of Disease Study 2013. , 2016, The Lancet. Infectious diseases.

[15]  E. Undurraga,et al.  Persistent Symptoms of Dengue: Estimates of the Incremental Disease and Economic Burden in Mexico , 2016, The American journal of tropical medicine and hygiene.

[16]  Fernanda Montenegro de Carvalho Araújo,et al.  Postmortem Diagnosis of Dengue as an Epidemiological Surveillance Tool. , 2016, The American journal of tropical medicine and hygiene.

[17]  O. Horstick,et al.  Relevance of Non-communicable Comorbidities for the Development of the Severe Forms of Dengue: A Systematic Literature Review , 2016, PLoS neglected tropical diseases.

[18]  G. Carrasquilla,et al.  Costing Dengue Fever Cases and Outbreaks: Recommendations from a Costing Dengue Working Group in the Americas. , 2015, Value in health regional issues.

[19]  Mirjam Kretzschmar,et al.  Disability weights for the Global Burden of Disease 2013 study. , 2015, The Lancet. Global health.

[20]  W. Brouwer,et al.  Unpaid work in health economic evaluations. , 2015, Social science & medicine.

[21]  Dagna Constenla,et al.  Assessing the Economics of Dengue: Results from a Systematic Review of the Literature and Expert Survey , 2015, PharmacoEconomics.

[22]  O. Horstick,et al.  Reviewing Dengue: Still a Neglected Tropical Disease? , 2015, PLoS neglected tropical diseases.

[23]  S. Halstead,et al.  Economic and Disease Burden of Dengue in Mexico , 2015, PLoS neglected tropical diseases.

[24]  Bernadette A. Thomas,et al.  Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 , 2015, The Lancet.

[25]  Bernadette A. Thomas,et al.  Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 , 2015, The Lancet.

[26]  C. Jo,et al.  Cost-of-illness studies: concepts, scopes, and methods , 2014, Clinical and molecular hepatology.

[27]  A. AdaljaAmesh,et al.  An estimate of the global health care and lost productivity costs of dengue. , 2014 .

[28]  O. Horstick,et al.  Dengue Disease Surveillance: Improving Data for Dengue Control , 2014, PLoS neglected tropical diseases.

[29]  S. Halstead,et al.  Approaches to Refining Estimates of Global Burden and Economics of Dengue , 2014, PLoS neglected tropical diseases.

[30]  N. King,et al.  Disability weights in the global burden of disease 2010 study: two steps forward, one step back? , 2014, Bulletin of the World Health Organization.

[31]  A. Farlow,et al.  Cost of dengue outbreaks: literature review and country case studies , 2013, BMC Public Health.

[32]  Bernard Cazelles,et al.  Spatiotemporal Dynamics of Dengue Epidemics, Southern Vietnam , 2013, Emerging infectious diseases.

[33]  E. Nord.  Disability weights in the Global Burden of Disease 2010: unclear meaning and overstatement of international agreement. , 2013, Health policy.

[34]  W. Brouwer,et al.  Productivity Costs in Economic Evaluations: Past, Present, Future , 2013, PharmacoEconomics.

[35]  John S. Brownstein,et al.  The global distribution and burden of dengue , 2013, Nature.

[36]  David Moher,et al.  Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement , 2013, Cost Effectiveness and Resource Allocation.

[37]  E. Undurraga,et al.  Economic and Disease Burden of Dengue in Southeast Asia , 2013, PLoS neglected tropical diseases.

[38]  E. Undurraga,et al.  Use of Expansion Factors to Estimate the Burden of Dengue in Southeast Asia: A Systematic Analysis , 2013, PLoS neglected tropical diseases.

[39]  Alan D. Lopez,et al.  Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010 , 2012, The Lancet.

[40]  Mohsen Naghavi,et al.  GBD 2010: design, definitions, and metrics , 2012, The Lancet.

[41]  Bernadette A. Thomas,et al.  Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 , 2012, The Lancet.

[42]  B. Kay,et al.  High household economic burden caused by hospitalization of patients with severe dengue fever cases in Can Tho province, Vietnam. , 2012, The American journal of tropical medicine and hygiene.

[43]  D. Hausman.  Health, well-being, and measuring the burden of disease , 2012, Population Health Metrics.

[44]  P. Gething,et al.  Refining the Global Spatial Limits of Dengue Virus Transmission by Evidence-Based Consensus , 2012, PLoS neglected tropical diseases.

[45]  Amy C. Morrison,et al.  Underrecognized mildly symptomatic viremic dengue virus infections in rural Thai schools and villages. , 2012, The Journal of infectious diseases.

[46]  Cameron P. Simmons,et al.  Current concepts: Dengue , 2012 .

[47]  J. Muñoz-Jordán,et al.  Dengue Deaths in Puerto Rico: Lessons Learned from the 2007 Epidemic , 2012, PLoS neglected tropical diseases.

[48]  Rafael Lozano,et al.  Modeling causes of death: an integrated approach using CODEm , 2012, Population Health Metrics.

[49]  U. Haque,et al.  Population Density, Water Supply, and the Risk of Dengue Fever in Vietnam: Cohort Study and Spatial Analysis , 2011, PLoS medicine.

[50]  Y. Arima,et al.  Epidemiologic update on the dengue situation in the Western Pacific Region, 2011. , 2011, Western Pacific surveillance and response journal : WPSAR.

[51]  W. J. McBride,et al.  Contribution of dengue fever to the burden of acute febrile illnesses in Papua New Guinea: an age-specific prospective study. , 2011, The American journal of tropical medicine and hygiene.

[52]  H. Margolis,et al.  Health Economics of Dengue: A Systematic Literature Review and Expert Panel's Assessment , 2011, The American journal of tropical medicine and hygiene.

[53]  Donald S. Shepard,et al.  Economic Impact of Dengue Illness in the Americas , 2011, The American journal of tropical medicine and hygiene.

[54]  J. Salomon.  New disability weights for the global burden of disease. , 2010, Bulletin of the World Health Organization.

[55]  J. Lang,et al.  A prospective cohort study of dengue infection in schoolchildren in Long Xuyen, Viet Nam. , 2010, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[56]  G. N. Nascentes,et al.  [Persistence of dengue symptoms in patients in Uberaba, Minas Gerais State, Brazil]. , 2010, Cadernos de saude publica.

[57]  D. Mavalankar,et al.  Quantifying the Impact of Chikungunya and Dengue on Tourism Revenues , 2009 .

[58]  A. Galvani,et al.  Disability adjusted life years lost to dengue in Brazil , 2009, Tropical medicine & international health : TM & IH.

[59]  Majid Ezzati,et al.  Measuring the Burden of Neglected Tropical Diseases: The Global Burden of Disease Framework , 2007, PLoS neglected tropical diseases.

[60]  D. Mont.  Measuring health and disability , 2007, The Lancet.

[61]  F. Rönsholt,et al.  The economic impact of dengue hemorrhagic fever on family level in Southern Vietnam. , 2007, Danish medical bulletin.

[62]  A. Nisalak,et al.  Burden of symptomatic dengue infection in children at primary school in Thailand: a prospective study , 2007, The Lancet.

[63]  R. Cummins,et al.  Measuring health in a vacuum: examining the disability weight of the DALY. , 2003, Health policy and planning.

[64]  E. Nord,et al.  Cross-national agreement on disability weights: the European Disability Weights Project , 2003, Population health metrics.

[65]  S. Halstead,et al.  Accelerating the development and introduction of a dengue vaccine for poor children, 5-8 December 2001, Ho Chi Minh City, VietNam. , 2002, Vaccine.

[66]  W. Weerdt,et al.  The global burden of disease disability weights , 2000, The Lancet.

[67]  L. Kumaranayake,et al.  The real and the nominal? Making inflationary adjustments to cost and other economic data. , 2000, Health policy and planning.

[68]  E. Nord,et al.  The value of DALY life: problems with ethics and validity of disability adjusted life years , 1999, BMJ.

[69]  D. Gubler,et al.  Using disability-adjusted life years to assess the economic impact of dengue in Puerto Rico: 1984-1994. , 1998, The American journal of tropical medicine and hygiene.

[70]  M. Koopmanschap,et al.  Patient and Informal Caregiver Time in Cost-Effectiveness Analysis: A Response to the Recommendations of the Washington Panel , 1998, International Journal of Technology Assessment in Health Care.

[71]  S. Anand,et al.  Disability-adjusted life years: a critical review. , 1997, Journal of health economics.

[72]  J. Barendregt,et al.  Global burden of disease , 1997, The Lancet.

[73]  E. Nord.  The Person-trade-off Approach to Valuing Health Care Programs , 1995, Medical decision making : an international journal of the Society for Medical Decision Making.

[74]  Dengue vaccine: WHO position paper – July 2016. , 2016, Releve epidemiologique hebdomadaire.

[75]  Y. Arima,et al.  Epidemiological update on the dengue situation in the Western Pacific Region, 2012. , 2015, Western Pacific surveillance and response journal : WPSAR.

[76]  A. Adalja,et al.  An estimate of the global health care and lost productivity costs of dengue. , 2014, Vector borne and zoonotic diseases.

[77]  G. Carrasquilla,et al.  Costing Dengue Cases And Outbreaks : A Guide To Current Practices And Procedures , 2012 .

[78]  E. Lim,et al.  Post-infectious fatigue syndrome in dengue infection. , 2007, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[79]  D. Fryback,et al.  HALYS and QALYS and DALYS, Oh My: similarities and differences in summary measures of population Health. , 2002, Annual review of public health.

[80]  D. Gubler,et al.  Impact of dengue/dengue hemorrhagic fever on the developing world. , 1999, Advances in virus research.

[81]  Alan D. Lopez,et al.  The global burden of disease: a comprehensive assessment of mortality and disability from diseases injuries and risk factors in 1990 and projected to 2020. , 1996 .

[82]  C. Murray,et al.  Global burden of disease , 1997, The Lancet.